Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1969 1
1970 1
1971 3
1972 1
1973 2
1974 5
1975 1
1977 8
1978 3
1979 6
1980 8
1981 8
1982 4
1983 5
1984 9
1985 9
1986 6
1987 6
1988 7
1989 17
1990 10
1991 10
1992 14
1993 15
1994 15
1995 5
1996 9
1997 9
1998 12
1999 8
2000 15
2001 18
2002 14
2003 19
2004 10
2005 4
2006 8
2007 10
2008 12
2009 13
2010 24
2011 39
2012 31
2013 31
2014 19
2015 10
2016 18
2017 21
2018 15
2019 16
2020 34
2021 30
2022 17
2023 20
2024 20
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

663 results

Results by year

Filters applied: . Clear all
Page 1
Autophagy in metabolic disease and ageing.
Kitada M, Koya D. Kitada M, et al. Nat Rev Endocrinol. 2021 Nov;17(11):647-661. doi: 10.1038/s41574-021-00551-9. Epub 2021 Sep 10. Nat Rev Endocrinol. 2021. PMID: 34508250 Review.
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Shimizu A, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Kinoshita T, Kai Y, Kitada M, Sato Y, Jimbo K, Sato N, Ishiguro H, Takada M, Ohashi Y, Ohno S. Toi M, et al. Among authors: kitada m. Lancet Oncol. 2021 Jan;22(1):74-84. doi: 10.1016/S1470-2045(20)30534-9. Lancet Oncol. 2021. PMID: 33387497 Clinical Trial.
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope.
Miyamoto S, Heerspink HJL, de Zeeuw D, Sakamoto K, Yoshida M, Toyoda M, Suzuki D, Hatanaka T, Nakamura T, Kamei S, Murao S, Hida K, Ando S, Akai H, Takahashi Y, Kitada M, Sugano H, Nunoue T, Nakamura A, Sasaki M, Nakatou T, Fujimoto K, Kawanami D, Wada T, Miyatake N, Kuramoto H, Shikata K; CANPIONE study Investigators. Miyamoto S, et al. Among authors: kitada m. Kidney Int. 2024 Nov;106(5):972-984. doi: 10.1016/j.kint.2024.08.019. Epub 2024 Aug 30. Kidney Int. 2024. PMID: 39216659 Free article. Clinical Trial.
Radiation-Associated Breast Angiosarcoma.
Yoshino R, Yoshida N, Ujiie N, Ito A, Nakatsubo M, Kamikokura Y, Kitada M. Yoshino R, et al. Among authors: kitada m. Cureus. 2023 Oct 8;15(10):e46673. doi: 10.7759/cureus.46673. eCollection 2023 Oct. Cureus. 2023. PMID: 37942397 Free PMC article.
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial.
Yamashita T, Saji S, Takano T, Naito Y, Tsuneizumi M, Yoshimura A, Takahashi M, Tsurutani J, Iwatani T, Kitada M, Tada H, Mori N, Higuchi T, Iwasa T, Araki K, Koizumi K, Hasegawa H, Uchida Y, Morita S, Masuda N. Yamashita T, et al. Among authors: kitada m. J Clin Oncol. 2025 Apr 10;43(11):1302-1313. doi: 10.1200/JCO-24-01888. Epub 2025 Jan 9. J Clin Oncol. 2025. PMID: 39787453 Free PMC article. Clinical Trial.
Sirtuins and Renal Oxidative Stress.
Ogura Y, Kitada M, Koya D. Ogura Y, et al. Among authors: kitada m. Antioxidants (Basel). 2021 Jul 27;10(8):1198. doi: 10.3390/antiox10081198. Antioxidants (Basel). 2021. PMID: 34439446 Free PMC article. Review.
663 results